BioLineRx Teams Up with St. Jude for Gene Therapy Research
Thursday, 30 May 2024, 08:24
BioLineRx Announces Collaboration with St. Jude Children's Research Hospital
BioLineRx has partnered with St. Jude Children's Research Hospital in a clinical trial agreement to evaluate the effectiveness of Motixafortide in mobilizing CD34+ Hematopoietic Stem Cells for gene therapy applications. The collaboration intends to unlock the full potential of Motixafortide in improving gene therapy efficacy, especially in addressing hematologic conditions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.